print_label | resize_label

THE BOARD

 

  • Prof. Dr. JL. Balligand
    UCL
  • Prof. Dr. J. De Greve
    VUB
  • Prof. Ir. B. De Moor
    KUL
  • H. Dussart
    Country President AstraZeneca BeLux
  • Prof. Dr. M. Goldman
    Institute for Interdisciplinary Innovation in healthcare
  • Prof. Dr. J. Denekens
    University Antwerp
  • Prof. Dr. L. Annemans
    University Ghent
  • L. Wollaert
    Gov. Aff. & Market Access Director AstraZeneca BeLux
  •  

Our History

 
 

The AstraZeneca Foundation was established by AstraZeneca as an independent structure. The Foundation was created in 1993 as a result of new insights that had been developed regarding innovation in the fields of medication, medical techniques and management, as well as guidelines for the healthcare sector.

Innovation

Innovation

 
 

New perspectives on the social and ethical responsibility of all stakeholders in the medical world also played an important role in this regard. Due to its efforts to offer innovative clinical solutions to current and future medical needs, the pharmaceutical industry is of course one of the key stakeholders in this area.

Social Commitment

Social Commitment

 
 

The AstraZeneca Foundation wants to make a social commitment in Belgium ensuring that its efforts have a positive impact on the lives of the patients and on society. Since 1993, the Foundation has already invested EUR 4.6 million towards this goal.

board3

NS Approval ID 1009870 Revision date 09/2016